Explore Products
Transfected Stable Cell Lines

Human ERBB2 (R678Q) BAF3 Cell Line

  • BSL

    1

  • 57
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-X0005C

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Transfected Stable Cell Lines
Size/Quantity

1 vial

Cell Type

Lymphocyte

Shipping Info

Dry Ice

Growth Conditions

37 °C, 5% CO₂

Source Organ

Lymphatic

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Overexpression Stable Cell Lines

Host Cell

BAF3

Description

Human ERBB2 (R678Q) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. ERBB2 (R678Q) BAF3 mutant cell line is generated by stable integration of exogenous human ERBB2 gene harboring the R678Q point mutation into Ba/F3 host cells using our optimized transduction of lentiviral vectors.
Target
The ERBB2 (HER2) gene encodes a transmembrane receptor tyrosine kinase critical for cell signaling cascades that control proliferation and survival. The R678Q mutation lies in the juxtamembrane domain and has been associated with enhanced dimerization and receptor activation independent of ligand binding. This mutation contributes to oncogenesis by triggering sustained downstream signaling, notably through MAPK and PI3K/AKT pathways, and has been reported in lung adenocarcinoma and other solid tumors. AcceGen offers generation of stable mutation-specific or overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.

View Product Image

Application

  • For research use only

  • The ERBB2 (R678Q) BAF3 Cell Line serves as a powerful tool to investigate HER2-juxtamembrane mutation-driven oncogenic mechanisms and therapeutic interventions. This model enables studies of dimerization-mediated activation, IL-3-independent growth, and resistance to tyrosine kinase inhibitors. It is utilized for high-throughput screening of HER2-targeted therapies and evaluation of combination treatment strategies.

Inquiring Human ERBB2 (R678Q) BAF3 Cell Line

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button